~t t h e c h i l d r e n ' s -c e n t e r o i t h e ~o u n t S i n a i H o s~i t a l a u a n t it a t i v e measurements o f serum C -r e a c t i v e p r o t e i n ( C R P ) are f r eq u e n t l y made. We have performed more t h a n 30,000 such t e s t s s i n c e 1974. A serum CRP d e t e r m i n a t i o n i s made whenever a b l o o d c u l t u r e i s obtained.
these 18 episodes, i t was < 1 m g l d l . Three c h i l d r e n (4 e p isodes) were on chemotherapy f o r ma1 ignancy. Three c h i l d r e n d i e d t h e day o f t h e d e t e r m i n a t i o n s . The remaining c h i l d r e n had s e ri o u s i n f e c t i o n s w i t h a v a r i e t y o f d i f f e r e n t agents, i n c l u d i n g H. i n f l u e n z a e , S. pneumoniae, S. aureus, Ps. aerugenosa, group B streptococcus, salmonella species, K. pneumoniae, E. cloacae and candida species.
Our d a t a i l l u s t r a t e t h a t a normal i n i t i a l CRP v a l u e i s n o t i n c o n s i s t e n t w i t h septicemia.
Physicians u s i n g CRP measurements f o r d i a g n o s t i c purposes should be aware o f t h i s . The purpose of this study was to evaluate the CBS LA test prospectively over 3.5 years in a hospital laboratory. Between 4/1/80 and 11/30/83, 869 urine samples and 302 cerebrospinal fluid (CSF) samples from 1035 patients evaluated for GBS sepsis and/or meningitis were tested by GBS LA. All patients had a blood culture and 302 also had a CSF culture for suspected meningitis. Seventeen patients had culture positive GBS sepsis or meningitis. Thirty-one patients had a positive GBS LA test for GBS antigen. Of these 31, 12 had GBS sepsis and/or meningitis by culture, 13 had GBS surface or gastrointestinal colonization but sterile blood + CSF cultures, and 6 had no evidence of GBS colonization or infection. The fatality rate was highest in patients with intraabdominal (18.4%) and CNS (14%) infections, lo bacteremia (13%) and pneumonia (9%). However, many of the deaths were not the direct result of the NI.
MODERATE SENSITIVITY, HIGH SPECIFICITY, AND LOW
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Infection control personnel determined that 142 (30%) of the 474 deaths were caused by the NI. The proportion of deaths that were caused by the NI was similar at medical school affiliated and non affiliated hospitals (30% vs 252, p>0.05). The proportion of infections in which the NI caused death was highest for CNS (11%) and intraabdominal (9.5%) infections. NI associated with 2 ' bacteremia caused death approximately 6 times more often then those without 2 ' bacteremia (5.5% vs 0.93%. p<0.001). NI with gram-negative bacilli resistant to gentamicin or tobramycin caused death more often then those with susceptible strains (7.9% vs 1.82, p <0.001). Infection control efforts should be focused on the prevention of those pediatric NI associated with the highest mortality.
ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) IN PEDIAT-
Chorba, Bruce L. Evatt (Spon. by Roger A. Feldman) Centers for Disease Control, Atlanta, GA Three of 35 U.S. children (<I8 vears old) with AIDS re~orted to the Centers for Disease Control (CDC) as of December 1983 had hemophilia. We summarize these and 2 European pediatric AIDS patients with hemophilia, reported to CDC. All 5 patients were white and male; ages ranged from 9-16 years. Four patients had severe hemophilia A; 1, moderate hemophilia B. Two cases resided in New York; 1, in Pennsylvania; the European cases were Spanish and siblings. Four patients presented with fever and weight loss; all had pulmonary symptoms. All cases had laboratory findings consistent with AIDS and had opportunistic infections (01) including Pneumocystis carinii pneumonia, systemic cytomegalovirus, and systemic fungal infections. Three patients (60%) have died. None had other known risk factors for AIDS or imunosuppressive therapy. The hemophilia B patient received 2 units of whole blood in 1982 and no other blood products. Factor VIII was the only blood product received by both U.S. hemophilia A patients in the past 5 years. The prevalence of hemophilia in pediatric AIDS patients is much higher than its estimated population prevalence (1 in 10,000), indicating that hemophilia is a risk factor for AIDS. AIDS may occur in those receiving only factor or only whole blood therapy. Pediatricians should consider AIDS in any patient with hemophilia and unexplained weight loss, fever, or 01. To help further clarify the role of blood products in AIDS transmission, they should inquire about all product usage and other AIDS risk factors. CMV causes congenital infection in 0.5-2% of births and may be the leading cause of congenital deafness in the U.S. Personnel in centers for developmentally delayed infants and toddlers are concerned that admission of children known to have CMV may increase the transmission of CMV to pregnant staff and the risk of subsequent congenital infection. Despite lack of data to warrant this assumption, children are denied services because they shed CMV. Ve studied C W shedding in urine and saliva in children 0-3 yrs. in day care (DCC) and infant development centers (IDC) and the CMV immunity of the staff (58 staff in 6 DCC and 72 staff in 10 IDC). 59% of DCC and 42% of IDC staff were seropositive. Among staff, seropositivity did not differ by center type, age, or socioeconomic status (SES). There was no positive correlation between seropositivity and length of employment. Among 100 children in 4 DCC and 62 children in 7 IDC, 21% and 22% respectively had CMV urinary shedding. There were no significant differences by age, center type, ambulatory status, or center SES. Thus, CMV urinary shedding is common in these settings. Since 48% of the staff under 35 are seronegative, rates of shedding among the children are of concern. Seroconversion rates among staff working with young children need to be established and more learned about transmission of CMV. Nevertheless, we found no difference between DCC and IDC: thus, staff in IDC are no more likely to have acquired CMV than DCC staff, and there is no indication for excluding known CMV shedders from IDC.
